vs
Side-by-side financial comparison of Agilent Technologies (A) and Invesco (IVZ). Click either name above to swap in a different company.
Agilent Technologies is the larger business by last-quarter revenue ($1.8B vs $1.7B, roughly 1.1× Invesco). Agilent Technologies runs the higher net margin — 17.0% vs -58.9%, a 75.8% gap on every dollar of revenue. On growth, Agilent Technologies posted the faster year-over-year revenue change (7.0% vs 6.2%). Invesco produced more free cash flow last quarter ($432.2M vs $175.0M). Over the past eight quarters, Invesco's revenue compounded faster (7.1% CAGR vs 6.9%).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.
A vs IVZ — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $1.7B |
| Net Profit | $305.0M | $-995.9M |
| Gross Margin | 52.6% | — |
| Operating Margin | 19.6% | -86.2% |
| Net Margin | 17.0% | -58.9% |
| Revenue YoY | 7.0% | 6.2% |
| Net Profit YoY | -4.1% | -575.8% |
| EPS (diluted) | $1.07 | $-2.61 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.9B | $1.7B | ||
| Q3 25 | $1.7B | $1.6B | ||
| Q2 25 | $1.7B | $1.5B | ||
| Q1 25 | $1.7B | $1.5B | ||
| Q4 24 | $1.7B | $1.6B | ||
| Q3 24 | $1.6B | $1.5B | ||
| Q2 24 | $1.6B | $1.5B |
| Q1 26 | $305.0M | — | ||
| Q4 25 | $434.0M | $-995.9M | ||
| Q3 25 | $336.0M | $356.4M | ||
| Q2 25 | $215.0M | $197.4M | ||
| Q1 25 | $318.0M | $171.1M | ||
| Q4 24 | $351.0M | $209.3M | ||
| Q3 24 | $282.0M | $55.0M | ||
| Q2 24 | $308.0M | $132.2M |
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | — | ||
| Q3 25 | 51.1% | — | ||
| Q2 25 | 51.9% | — | ||
| Q1 25 | 53.5% | — | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 54.2% | — | ||
| Q2 24 | 54.4% | — |
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | -86.2% | ||
| Q3 25 | 20.7% | 16.5% | ||
| Q2 25 | 18.0% | 14.1% | ||
| Q1 25 | 22.4% | 18.1% | ||
| Q4 24 | 24.0% | 19.6% | ||
| Q3 24 | 21.1% | 6.6% | ||
| Q2 24 | 23.1% | 13.9% |
| Q1 26 | 17.0% | — | ||
| Q4 25 | 23.3% | -58.9% | ||
| Q3 25 | 19.3% | 21.7% | ||
| Q2 25 | 12.9% | 13.0% | ||
| Q1 25 | 18.9% | 11.2% | ||
| Q4 24 | 20.6% | 13.1% | ||
| Q3 24 | 17.9% | 3.6% | ||
| Q2 24 | 19.6% | 8.9% |
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | $-2.61 | ||
| Q3 25 | $1.18 | $0.66 | ||
| Q2 25 | $0.75 | $-0.03 | ||
| Q1 25 | $1.11 | $0.38 | ||
| Q4 24 | $1.23 | $0.46 | ||
| Q3 24 | $0.97 | $0.12 | ||
| Q2 24 | $1.05 | $0.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | $1.0B |
| Total DebtLower is stronger | $3.0B | $1.8B |
| Stockholders' EquityBook value | $6.9B | $12.2B |
| Total Assets | $12.8B | $27.1B |
| Debt / EquityLower = less leverage | 0.44× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | $1.0B | ||
| Q3 25 | $1.5B | $973.1M | ||
| Q2 25 | $1.5B | $922.7M | ||
| Q1 25 | $1.5B | $821.7M | ||
| Q4 24 | $1.3B | $986.5M | ||
| Q3 24 | $1.8B | $1.0B | ||
| Q2 24 | $1.7B | $878.5M |
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | $1.8B | ||
| Q3 25 | $3.4B | $1.6B | ||
| Q2 25 | $3.3B | $1.9B | ||
| Q1 25 | $3.3B | $964.8M | ||
| Q4 24 | $3.3B | $890.6M | ||
| Q3 24 | $2.1B | $890.3M | ||
| Q2 24 | $2.1B | $890.1M |
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.7B | $12.2B | ||
| Q3 25 | $6.4B | $14.0B | ||
| Q2 25 | $6.1B | $13.9B | ||
| Q1 25 | $6.0B | $14.7B | ||
| Q4 24 | $5.9B | $14.6B | ||
| Q3 24 | $5.9B | $14.8B | ||
| Q2 24 | $6.2B | $14.6B |
| Q1 26 | $12.8B | — | ||
| Q4 25 | $12.7B | $27.1B | ||
| Q3 25 | $12.2B | $28.4B | ||
| Q2 25 | $12.2B | $28.5B | ||
| Q1 25 | $11.9B | $28.1B | ||
| Q4 24 | $11.8B | $27.0B | ||
| Q3 24 | $11.0B | $27.5B | ||
| Q2 24 | $10.9B | $27.2B |
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | 0.15× | ||
| Q3 25 | 0.53× | 0.12× | ||
| Q2 25 | 0.55× | 0.14× | ||
| Q1 25 | 0.56× | 0.07× | ||
| Q4 24 | 0.57× | 0.06× | ||
| Q3 24 | 0.36× | 0.06× | ||
| Q2 24 | 0.34× | 0.06× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $268.0M | $455.8M |
| Free Cash FlowOCF − Capex | $175.0M | $432.2M |
| FCF MarginFCF / Revenue | 9.7% | 25.5% |
| Capex IntensityCapex / Revenue | 5.2% | 1.4% |
| Cash ConversionOCF / Net Profit | 0.88× | — |
| TTM Free Cash FlowTrailing 4 quarters | $993.0M | $1.4B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $455.8M | ||
| Q3 25 | $362.0M | $606.2M | ||
| Q2 25 | $221.0M | $547.9M | ||
| Q1 25 | $431.0M | $-84.6M | ||
| Q4 24 | $481.0M | $316.9M | ||
| Q3 24 | $452.0M | $438.4M | ||
| Q2 24 | $333.0M | $489.1M |
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $432.2M | ||
| Q3 25 | $259.0M | $586.4M | ||
| Q2 25 | $107.0M | $530.4M | ||
| Q1 25 | $334.0M | $-108.0M | ||
| Q4 24 | $388.0M | $309.9M | ||
| Q3 24 | $360.0M | $410.0M | ||
| Q2 24 | $230.0M | $462.4M |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | 25.5% | ||
| Q3 25 | 14.9% | 35.7% | ||
| Q2 25 | 6.4% | 35.0% | ||
| Q1 25 | 19.9% | -7.1% | ||
| Q4 24 | 22.8% | 19.5% | ||
| Q3 24 | 22.8% | 27.1% | ||
| Q2 24 | 14.6% | 31.2% |
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | 1.4% | ||
| Q3 25 | 5.9% | 1.2% | ||
| Q2 25 | 6.8% | 1.2% | ||
| Q1 25 | 5.8% | 1.5% | ||
| Q4 24 | 5.5% | 0.4% | ||
| Q3 24 | 5.8% | 1.9% | ||
| Q2 24 | 6.5% | 1.8% |
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | — | ||
| Q3 25 | 1.08× | 1.70× | ||
| Q2 25 | 1.03× | 2.78× | ||
| Q1 25 | 1.36× | -0.49× | ||
| Q4 24 | 1.37× | 1.51× | ||
| Q3 24 | 1.60× | 7.97× | ||
| Q2 24 | 1.08× | 3.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
IVZ
| Investment Advice | $1.2B | 73% |
| Distribution And Shareholder Service | $382.7M | 23% |
| Financial Service Other | $51.0M | 3% |
| Investment Performance | $28.9M | 2% |
